Key points are not available for this paper at this time.
SH is associated with the risk of incident CVEs. Besides the clinical follow-up, in patients with an AI >2.4 cm, a long-term biochemical follow-up is also required because of the risk of SH development.
Morelli et al. (Tue,) studied this question.